Robert L. Balster

Virginia Commonwealth University — United States

Neuroscience · Life Sciences

63h-index14.6kcitations3.5kworks0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Neurotransmitter Receptor Influence on Behavior(140), Neuroscience and Neuropharmacology Research(113), Receptor Mechanisms and Signaling(45), Pharmacological Effects and Toxicity Studies(44), Attention Deficit Hyperactivity Disorder(41)

Publications1.1k total

To Stop or Not to Stop Cannabis Use in Pregnancy: Characteristics Associated With Late 3rd Trimester Use
Drug and Alcohol Dependence·2025
Answering questions about electronic cigarettes using a multidisciplinary model.
American Psychologist·2019· 1 citedOpen Access
Smoking Behaviors in Arab Americans: Acculturation and Health Beliefs
Journal of Transcultural Nursing·2018· 16 cited
Reviewing Manuscripts for Scientific Journals
Ubiquity Press eBooks·2017· 4 citedOpen Access
Ensure global access to naloxone for opioid overdose management
Addiction·2016· 5 citedOpen Access
Acknowledgment of Ad Hoc Reviewers
Experimental and Clinical Psychopharmacology·2016· 1 citedOpen Access
Inhalant Abuse
2015
Abuse Liability Evaluation
2015
William L Woolverton
Neuropsychopharmacology·2014Open Access
Interview with Eddy Award Winner Dr Robert Balster
Drug and Alcohol Dependence·2014
William L. Woolverton: A case history in unraveling the behavioral pharmacology of stimulants
Neuropharmacology·2014· 4 citedOpen Access
Evidence Acquisition and Evaluation for Evidence Summit on Population-Level Behavior Change to Enhance Child Survival and Development in Low- and Middle-Income Countries
Journal of Health Communication·2014· 11 citedOpen Access
Financial incentives and maternal health: where do we go from here?
PubMed·2013· 54 cited
Evidence acquisition and evaluation for evidence summit on enhancing provision and use of maternal health services through financial incentives.
PubMed·2013· 4 cited
Abuse liability measures for use in analgesic clinical trials in patients with pain: IMMPACT recommendations
Pain·2013· 48 cited
Obituary: William L. Woolverton
Psychopharmacology·2013Open Access
Correction: GLYX-13, a NMDA Receptor Glycine-Site Functional Partial Agonist, Induces Antidepressant-Like Effects Without ketamine-like Side Effects
Neuropsychopharmacology·2013· 3 citedOpen Access
Abuse Liability Evaluation
2013
Inhalant Abuse
2013
Neuropharmacology of Inhalants
Elsevier eBooks·2013· 6 cited
page 1 of 57Next →

Frequent Co-authors

Wiepke Cahn(8), María Isabel Colado(6), Daniel Bertrand(6), Hans Rollema(6), H D Postma(6), Heleen B. M. Boos(5), Greg A. Gerhardt(4), Lynette C. Daws(4), Raymond S Hurst(4), Peter Riederer(4), Siegfried Hoyer(4), Caroline Cohen(4), Marc Turiault(4), Guy Griebel(4), Jenny L. Wiley(4), Sharon Walsh(3), Heleen B. M. Boos(3), Katherine L. Nicholson(3), Charles R. Schuster(3), Silvia L. Cruz(3)